The half-life of MariTide is 21 days, which supports monthly or less frequent injections [76]
A double-blind, randomized phase 2 study comparing various doses (1, 5, 10, 15 mg) of once weekly tirzepatide, dulaglutide (1.5 mg) and placebo, in patients with T2DM, showed tirzepatide was superior on weight loss and glucose-lowering compared to both dulaglutide and placebo [52]
Discuss your weight loss rate and nutritional intake with your GP or practice nurse to ensure safe, sustainable progress
Continued awareness, innovation, and access to effective therapies can make a meaningful difference
Multi-'omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic fatigue syndrome patients